These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27278657)

  • 1. JAK3-STAT pathway blocking benefits in experimental lupus nephritis.
    Ripoll È; de Ramon L; Draibe Bordignon J; Merino A; Bolaños N; Goma M; Cruzado JM; Grinyó JM; Torras J
    Arthritis Res Ther; 2016 Jun; 18(1):134. PubMed ID: 27278657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S; Yang N; Zhang L; Huang B; Tan H; Liang Y; Li Y; Yu X
    Lupus; 2010 Sep; 19(10):1171-80. PubMed ID: 20501525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
    Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
    J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of tricyclic JAK3 inhibitors with picomolar affinities as novel molecular probes.
    Gehringer M; Pfaffenrot E; Bauer S; Laufer SA
    ChemMedChem; 2014 Feb; 9(2):277-81. PubMed ID: 24403205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
    Dai Z; Chen J; Chang Y; Christiano AM
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor.
    Elwood F; Witter DJ; Piesvaux J; Kraybill B; Bays N; Alpert C; Goldenblatt P; Qu Y; Ivanovska I; Lee HH; Chiu CS; Tang H; Scott ME; Deshmukh SV; Zielstorff M; Byford A; Chakravarthy K; Dorosh L; Rivkin A; Klappenbach J; Pan BS; Kariv I; Dinsmore C; Slipetz D; Dandliker PJ
    J Pharmacol Exp Ther; 2017 May; 361(2):229-244. PubMed ID: 28193636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the JAK inhibitor CP-690,550 on peripheral immune parameters in stable kidney allograft patients.
    van Gurp EA; Schoordijk-Verschoor W; Klepper M; Korevaar SS; Chan G; Weimar W; Baan CC
    Transplantation; 2009 Jan; 87(1):79-86. PubMed ID: 19136895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q; Yang C; Wang Q; Zeng H; Qin W
    PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds.
    Migita K; Izumi Y; Torigoshi T; Satomura K; Izumi M; Nishino Y; Jiuchi Y; Nakamura M; Kozuru H; Nonaka F; Eguchi K; Kawakami A; Motokawa S
    Clin Exp Immunol; 2013 Dec; 174(3):356-63. PubMed ID: 23968543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating inflammation with the Janus kinase inhibitor CP-690,550.
    Vijayakrishnan L; Venkataramanan R; Gulati P
    Trends Pharmacol Sci; 2011 Jan; 32(1):25-34. PubMed ID: 21144599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Lee SW; Park KH; Park S; Kim JH; Hong SY; Lee SK; Choi D; Park YB
    Arthritis Rheum; 2013 Jul; 65(7):1902-12. PubMed ID: 23553192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
    Lescoat A; Lelong M; Jeljeli M; Piquet-Pellorce C; Morzadec C; Ballerie A; Jouneau S; Jego P; Vernhet L; Batteux F; Fardel O; Lecureur V
    Biochem Pharmacol; 2020 Aug; 178():114103. PubMed ID: 32562787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
    Alunno A; Padjen I; Fanouriakis A; Boumpas DT
    Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition.
    Sekine H; Ruiz P; Gilkeson GS; Tomlinson S
    Mol Immunol; 2011 Oct; 49(1-2):317-23. PubMed ID: 22000720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
    Gao W; McGarry T; Orr C; McCormick J; Veale DJ; Fearon U
    Ann Rheum Dis; 2016 Jan; 75(1):311-5. PubMed ID: 26353790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.
    Zhao J; Wang H; Huang Y; Zhang H; Wang S; Gaskin F; Yang N; Fu SM
    Arthritis Rheumatol; 2015 Apr; 67(4):1036-44. PubMed ID: 25512114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK/STAT signaling controls the fate of CD8
    Zhou M; Guo C; Li X; Huang Y; Li M; Zhang T; Zhao S; Wang S; Zhang H; Yang N
    J Autoimmun; 2020 May; 109():102424. PubMed ID: 32085893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.